EpimAb Biotherapeutics, Inc.
Advancing a Best-in-class Bispecific Antibody Format
40 employees · est. 2015 · Shanghai, China
Mabqi
Your key partner for breakthrough antibody discovery
26 employees · est. 2017 · Grabels, France
EpimAb Biotherapeutics, Inc. is the older company (2015 vs 2017).
Side-by-Side Comparison
| Metric | EpimAb Biotherapeutics, Inc. | Mabqi |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2017 |
| Headquarters | ||
| Headquarters | Shanghai, China | Grabels, France |
| Employees | ||
| Employees | 40 | 26 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series C | Not tracked yet |
| Total Funding | ||
| Total Funding | $219.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 3 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Discovery and development of fully human antibodies, Antibody Drug Discovery, Antibody Maturation, LiteMab Antibody Discovery Studio services |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotechnology Firms, Oncology Researchers, Clinical Research Organizations |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Bi-specific Antibodies, Oncology Therapeutics, Immuno-oncology, Monoclonal Antibodies, FIT-Ig Platform, CMC Development, Licensing Arrangements, Series A Funding, Drug Development, Pharmaceutical Industry, Novel Bi-specific Antibodies, China-based Startup, International Investors, Clinical Development | Antibody Discovery, Fully Human Antibody Discovery, Therapeutic Antibodies, Oncology Applications, Antibody Affinity Maturation, Antibody Optimization, PH-Sensitive Antibodies, Monoclonal Antibodies, Multispecific Antibodies, Synthetic Antibody Library, Phage Display, Yeast Display, Antibody Development, Immuno-Oncology, Bispecific Antibodies |
| Website | ||
| Website | epimab.com | mabqi.com |
About EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc., a China-based biopharmaceutical startup founded in 2015, is making strides in developing novel bi-specific antibodies in the fields of oncology and immune-oncology. The company's proprietary platform, FIT-Ig (Fabs in Tandem), has successfully produced multiple bispecifi...
About Mabqi
Mabqi, founded in 2017 and headquartered in France, is emerging as a pivotal player in the Biotechnology industry with its cutting-edge approaches to antibody discovery. Under its slogan, "Your key partner for breakthrough antibody discovery," the company leverages proprietary technology, employing...
We will tell you when either one moves
BounceWatch watches EpimAb Biotherapeutics, Inc. and Mabqi for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at EpimAb Biotherapeutics... and Mabqi — by email.
Frequently Asked Questions
Compare EpimAb Biotherapeutics, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at EpimAb Biotherapeutics, Inc. on 12 Sep 2024, and Mabqi on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
